Felix S F Ram

Summary

Country: UK

Publications

  1. ncbi Non-invasive positive pressure ventilation to treat respiratory failure resulting from exacerbations of chronic obstructive pulmonary disease: Cochrane systematic review and meta-analysis
    Josephine V Lightowler
    Department of Respiratory Medicine, St James's University Hospital, Leeds LS9 7TF
    BMJ 326:185. 2003
  2. ncbi Hospital at home for patients with acute exacerbations of chronic obstructive pulmonary disease: systematic review of evidence
    Felix S F Ram
    National Collaborating Centre for Women and Children s Health, London NW1 4RG
    BMJ 329:315. 2004
  3. ncbi Efficacy of theophylline in people with stable chronic obstructive pulmonary disease: a systematic review and meta-analysis
    F S F Ram
    National Collaborating Centre for Women s and Children s Health, London, UK
    Respir Med 99:135-44. 2005
  4. ncbi Use of theophylline in chronic obstructive pulmonary disease: examining the evidence
    Felix S F Ram
    School of Health Sciences, Massey University, Auckland, New Zealand
    Curr Opin Pulm Med 12:132-9. 2006
  5. ncbi Clinical effectiveness of the Respimat inhaler device in managing chronic obstructive pulmonary disease: evidence when compared with other handheld inhaler devices
    Felix S F Ram
    School of Health and Social Services, Massey University, Auckland, New Zealand
    Int J Chron Obstruct Pulmon Dis 6:129-39. 2011
  6. ncbi Clinical efficacy of inhaler devices containing beta(2)-agonist bronchodilators in the treatment of asthma: cochrane systematic review and meta-analysis of more than 100 randomized, controlled trials
    Felix S F Ram
    National Collaborating Centre for Women and Children's Health, Royal College of Obstetricians and Gynaecologists, London, UK
    Am J Respir Med 2:349-65. 2003
  7. ncbi Evidence-based resource use by practice nurses in the Greater Auckland region of New Zealand
    Karen J Hoare
    Goodfellow Unit, School of Nursing, ProCare Department of General Practice and Primary Health Care, School of Population Health, The University of Auckland, Private Bag 92019, Auckland, New Zealand
    N Z Med J 121:51-8. 2008
  8. ncbi Airway mucosal inflammation in COPD is similar in smokers and ex-smokers: a pooled analysis
    E Gamble
    Department of Respiratory Medicine, London Chest Hospital, Bonner Road, London, UK
    Eur Respir J 30:467-71. 2007

Detail Information

Publications8

  1. ncbi Non-invasive positive pressure ventilation to treat respiratory failure resulting from exacerbations of chronic obstructive pulmonary disease: Cochrane systematic review and meta-analysis
    Josephine V Lightowler
    Department of Respiratory Medicine, St James's University Hospital, Leeds LS9 7TF
    BMJ 326:185. 2003
    ..NPPV should be tried early in the course of respiratory failure and before severe acidosis, to reduce mortality, avoid endotracheal intubation, and decrease treatment failure...
  2. ncbi Hospital at home for patients with acute exacerbations of chronic obstructive pulmonary disease: systematic review of evidence
    Felix S F Ram
    National Collaborating Centre for Women and Children s Health, London NW1 4RG
    BMJ 329:315. 2004
    ..To evaluate the efficacy of hospital at home schemes compared with inpatient care in patients with acute exacerbations of chronic obstructive pulmonary disease (COPD)...
  3. ncbi Efficacy of theophylline in people with stable chronic obstructive pulmonary disease: a systematic review and meta-analysis
    F S F Ram
    National Collaborating Centre for Women s and Children s Health, London, UK
    Respir Med 99:135-44. 2005
    ..To determine the efficacy of oral theophylline compared with placebo in people with stable chronic obstructive pulmonary disease (COPD)...
  4. ncbi Use of theophylline in chronic obstructive pulmonary disease: examining the evidence
    Felix S F Ram
    School of Health Sciences, Massey University, Auckland, New Zealand
    Curr Opin Pulm Med 12:132-9. 2006
    ..The role of theophylline in the management of chronic obstructive pulmonary disease remains controversial. This review was undertaken to determine the efficacy of theophylline in patients with stable disease...
  5. ncbi Clinical effectiveness of the Respimat inhaler device in managing chronic obstructive pulmonary disease: evidence when compared with other handheld inhaler devices
    Felix S F Ram
    School of Health and Social Services, Massey University, Auckland, New Zealand
    Int J Chron Obstruct Pulmon Dis 6:129-39. 2011
    ..This study was undertaken to determine the clinical effectiveness of the Respimat handheld inhaler device compared with other handheld inhaler devices for the delivery of medication in stable COPD...
  6. ncbi Clinical efficacy of inhaler devices containing beta(2)-agonist bronchodilators in the treatment of asthma: cochrane systematic review and meta-analysis of more than 100 randomized, controlled trials
    Felix S F Ram
    National Collaborating Centre for Women and Children's Health, Royal College of Obstetricians and Gynaecologists, London, UK
    Am J Respir Med 2:349-65. 2003
    ..Clinical effectiveness studies that use an intention-to-treat analysis and report more patient-centered outcomes are required...
  7. ncbi Evidence-based resource use by practice nurses in the Greater Auckland region of New Zealand
    Karen J Hoare
    Goodfellow Unit, School of Nursing, ProCare Department of General Practice and Primary Health Care, School of Population Health, The University of Auckland, Private Bag 92019, Auckland, New Zealand
    N Z Med J 121:51-8. 2008
    ..To determine self-reported use of New Zealand's Guidelines Group (NZGG) and BPAC resources by practice nurses (PNs) in the Greater Auckland area of New Zealand...
  8. ncbi Airway mucosal inflammation in COPD is similar in smokers and ex-smokers: a pooled analysis
    E Gamble
    Department of Respiratory Medicine, London Chest Hospital, Bonner Road, London, UK
    Eur Respir J 30:467-71. 2007
    ..It is concluded that, in established chronic obstructive pulmonary disease, the bronchial mucosal inflammatory cell infiltrate is similar in ex-smokers and those that continue to smoke...